Question 1

What is Agendia's focus?

Accepted Answer

Agendia is focused on breast cancer treatment planning and oncology, providing genomic tests like MammaPrint and BluePrint to give actionable insights throughout a patient's breast cancer journey.

Question 2

What do Agendia's genomic tests provide?

Accepted Answer

Agendia's genomic tests help determine the likelihood of a patient's breast cancer recurring, the underlying genomics driving the tumor's growth, and a more complete understanding of each patient's breast cancer. This helps match patients to the right treatment at the right time to minimize under- and over-treatment and improve their quality of life.

Question 3

What are some of Agendia's key tests?

Accepted Answer

Agendia offers the MammaPrint test, which determines the risk of recurrence, and the BluePrint test, which provides molecular subtyping for better outcomes. The company also has other tests and is involved in ongoing clinical trials.

Question 4

What kind of data and evidence supports Agendia's tests?

Accepted Answer

Agendia's tests have been validated through landmark studies and data on their utility for patients with early-stage breast cancer. The company provides access to this data and the latest news to keep healthcare providers up-to-date.

Question 5

How can patients access Agendia's services?

Accepted Answer

Patients can order Agendia's tests through their healthcare providers. The company also provides financial support and partners with patient advocacy groups to support patients throughout their breast cancer journey.

Agendia

Company Overview

Company Name

Address

Website

Phone

Employees

About Agendia

Frequently Asked Questions about Agendia

What is Agendia's focus?

What do Agendia's genomic tests provide?

What are some of Agendia's key tests?

What kind of data and evidence supports Agendia's tests?

How can patients access Agendia's services?

Technologies Used

Social Profiles

Key Decision Makers